Drug Profile
KW 2581
Alternative Names: KW-2581Latest Information Update: 24 Oct 2008
Price :
$50
*
At a glance
- Originator Kyowa Hakko
- Class Estrenes; Small molecules; Sulfonamides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Breast cancer
Most Recent Events
- 24 Oct 2008 Discontinued - Preclinical for Breast cancer in Japan (unspecified route)
- 13 Jul 2004 KW 2581 is available for licensing(http://www.kyowa.co.jp/eng)
- 13 Jul 2004 Preclinical trials in Breast cancer in Japan (unspecified route)